Table 4

Impact on clinical outcome of the presence of the ITD mutation

FLT3WT/WT (N = 59)FLT3ITD/WT and FLT3ITD/− (N = 23)P
Clinical outcome
 Percentage of CR86770.33
DFS
 Median (months)52a80.03
 Percentage of DFS at 12 months (95% confidence interval)71 (62, 80)39 (29, 48)
Survival
 Median (months)46a110.14
 Percentage alive at 12 months (95% confidence interval)74 (65, 82)46 (36, 55)
  • a Nonparametric estimate of the median is not available. Tabled value represents the median assuming the survival estimates after the last observation follows an exponential curve.